Queen Mary University of London is pleased to announce that Professor Márta Korbonits has received the prestigious Rolf Gaillard Prize from the European Neuroendocrine Association (ENEA).
Professor Márta Korbonits
Funded by the Foundation for Research in Endocrinology, Diabetology and Metabolism, the Rolf Gaillard Prize is awarded to a member of ENEA who had outstanding contributions to basic, translational or clinical research in the field of neuroendocrinology.
“I am honoured to receive this prestigious prize in neuroendocrinology, a field so close to my heart. Research achievements are results of team work and I am grateful for my outstanding mentors, collaborators and trainees helping me over the years to make this journey so enjoyable” said Prof Márta Korbonits.
"Queen Mary are so proud that Márta Korbonits has been awarded this prize, which is testimony to the world-leading endocrinology at QMUL and Barts Health with major benefit for patients. "said Professor Sir Mark Caulfield, Vice Principal for Health for Queen Mary’s Faculty of Medicine and Dentistry.
About Márta Korbonits
Prof Korbonits is an internationally lead in the field of genetic endocrine tumour syndromes, especially regarding pituitary tumours. She has an outstanding track record on all aspects of academic medicine: original research, teaching, mentoring and scholarship with leading roles in UK & International learned societies.
She led ground-breaking work on the hormonal regulation of AMPK activity by ghrelin, cannabinoids and glucocorticoids, resulting most recently in a ground-breaking clinical trial. She is the world-leading expert on genetics of endocrine tumour syndromes, especially familial isolated pituitary adenomas and the pathophysiology of AIP and pioneered patient involvement in her research. Her national and international scholarly activity and enthusiastic postgraduate teaching greatly advanced the field of endocrinology.
Further information